Abstract
This report showed an inhibitory effect of cell proliferation on HL-60 human leukemic cells followed by modified C60s. Additionally, those C60s was capable to be phagocytosed by a macrophages differentiated from HL-60 cells. An adequate modification of C60 may become a candidate of therapeutic tools for cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
